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Abstract  Licensed wound care products containing manuka honey are available in Europe 25 
and Australasia for the topical treatment of wounds.  Bactericidal activity of manuka honey 26 
on Pseudomonas aeruginosa has been reported, but structural effects have not. The aim of 27 
this study was to investigate the inhibitory effects of manuka honey on the structural integrity 28 
of Psuedomonas aeruginoas ATTC 27853. The minimum inhibitory concentration (MIC) and 29 
the minimum bactericidal concentration (MBC) of manuka honey for Ps. aeruginosa were 30 
determined by a microtitre plate method, and the survival of bacteria exposed to a 31 
bactericidal concentration of manuka honey was monitored. The effects of a bactericidal 32 
concentration of manuka honey on the structure of the bacteria were investigated using 33 
scanning and transmission electron microscopy. MIC and MBC values of manuka honey 34 
against Ps. aeruginosa were 9.5 % (w/v) and 12% (w/v) respectively, and incubation at 370C 35 
in 20 % w/v manuka honey contained in nutrient broth demonstrated a bactericidal rather 36 
than a bacteriostatic effect. Using scanning electron microscopy, loss of structural integrity 37 
and marked changes in cell shape and surface were observed in honey-treated cultures.  38 
With transmission electron microscopy these changes were confirmed, and evidence of 39 
extensive cell disruption and lysis was found. 40 
 41 
Introduction. Honey is an ancient remedy that has recently been re-introduced for the 42 
treatment of acute and chronic wounds.  In modern times it has been used in both remote 43 
and conventional medical practice, with evidence in medical journals documenting the 44 
clinical use of honey applied topically to the wounds of more than 1000 patients (Molan, 45 
2006). Within the past two years wound care products containing honey from three 46 
distributors have attained drug tariff status in the UK, with Australasian honey derived from 47 
the nectar of the genus Leptospermum (manuka and jellybush) predominantly utilised. 48 
Tubes of gamma irradiated honey, honey impregnated tulle, honey and alginate dressings 49 
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and honey based ointments are available as licensed medical devices. Further wound care 50 
products are under development in several European and Australasian countries and clinical 51 
trials are in progress in the UK, Ireland, Denmark, Australia, New Zealand and South Africa. 52 
The availability of regulated products is expected to promote increased clinical use in 53 
conventional medicine. 54 
 55 
The benefits of honey for wounds are based on its antimicrobial properties and its ability to 56 
stimulate rapid wound healing (Blair & Carter, 2005; Molan, 2002). Antimicrobial activity 57 
extends to more than 80 species (Blair & Carter, 2005; Molan, 1992). Inhibition of pathogens 58 
capable of causing wound infection has been demonstrated (Cooper, Halas & Molan, 2002; 59 
Cooper, Molan & Harding, 2002; French, Cooper & Molan, 2005; Wahdan, 1998; Willix, 60 
Molan & Harfoot, 1992), with both antibiotic-resistant and antibiotic-sensitive strains 61 
exhibiting susceptibility to honey (Cooper, Halas & Molan, 2002; Cooper, Molan & Harding, 62 
2002; Karayil, Deshpande,  & Koppikar, 1998). There are many clinical reports of the 63 
clearance of infection by topical application of honey, including eradication of MRSA from 64 
colonised and infected wounds.  65 
 66 
Honey is a complex and variable natural product that contains more than 600 components 67 
(Bogdanov, Ruoff, & Oddo, 2004), so the search for specific inhibitors is complicated. The 68 
antimicrobial activity of honey is derived from multiple factors, with contributions from high 69 
sugar content, low water content, low acidity, hydrogen peroxide and phytochemicals (Molan 70 
1992). Using artificial honey preparations, bactericidal effects of diluted natural honey 71 
solutions that are independent of sugar content have been demonstrated (Cooper, Halas & 72 
Molan, 2002; Cooper, Molan & Harding, 2002). New Zealand manuka honey is derived from 73 
nectar collected by honeybees (Apis mellifera) foraging on Western tea tree (Leptospermum 74 
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scoparium). Unlike many honeys, the activity of this honey at low dilutions is not dependent 75 
on the production of hydrogen peroxide by glucose oxidase (Molan, 1992). However the 76 
identity of the components responsible for the inhibition of micro-organisms has not yet been 77 
discovered. Hence, cellular target sites and mechanisms of action have not yet been 78 
established, and structural effects of honey on bacteria have not been published.  This study, 79 
therefore, aims to investigate the effects of manuka honey on a bacterium commonly 80 
associated with wound infection, in order to gain insight into its effectiveness as an inhibitory 81 
agent. 82 
 83 
 84 
Materials and methods. A culture of Ps. aeruginosa ATCC 27853 was tested with a sample 85 
of manuka honey (M109) that was a gift from Prof. Molan of the University of Waikato, New 86 
Zealand. A sample of sterile manuka honey (SH) obtained from New Zealand Natural Food 87 
Company was used to determine MBC in the presence of protein because germination of 88 
endospores contained in M109 caused turbidity that masked the end-point. Antibacterial 89 
potency of the samples was related to phenol using a bioassay developed in New Zealand 90 
(Allen, Molan & Reid, 1991). M109 and SH had non-peroxide activity equivalent to 18 % 91 
(w/v) and 17 % (w/v) phenol, respectively. 92 
MIC was determined in 96-well, flat bottomed microtitre plates using double strength nutrient 93 
broth (Oxoid) and honey concentrations varying by 1 % (w/v) intervals in a total volume of 94 
200 μl. Overnight broth cultures of the test organism was used as an inoculum without 95 
dilution, and total viable cell counts were performed to check retrospectively that each well 96 
had received approximately 106 cells. Plates were incubated at 37 0C for 24 hours and 97 
turbidity measured at 400 nm in a plate reader (Anthos Labtec Instruments).  Positive (broth 98 
and inoculum) and negative (broth and honey) controls were included. Wells with the lowest 99 
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concentration without growth were recorded as MIC. MBC was determined by plating 20 μl 100 
from wells without growth onto nutrient agar (Oxoid) and incubating at 37 0C for 24 hours to 101 
find the lowest concentration without viable bacteria. Experiments were performed in 102 
duplicate on each of three occasions. 103 
A time-kill study was performed by inoculating 40 μl of an overnight culture of Ps. aeruginosa 104 
ATCC 27853 into 20 ml nutrient broth with and without 20 % (w/v) M109 and incubating at 105 
37 0C in a shaking water bath (120 cycles min-1) hours (the honey concentration was 106 
approximately twice the MIC value). Samples were removed at known intervals and Miles 107 
Misra surface drop counts performed.  108 
Electron microscopy was performed using test bacteria in either the exponential or stationary 109 
phase of growth by cultivation in isosensitest broth (Oxoid) at 37 0C in a shaking water bath 110 
for either 3 hours or overnight. Cells were harvested by centrifugation at 3000 g for 30 111 
minutes (MSE harrier 15/80 centrifuge, Sanyo) at room temperature and suspended in 112 
MOPS buffer (pH 7.2) with and without 20 % (w/v) manuka honey for 8 hours. Cells were 113 
examined in scanning (SEM) (5200LV Jeol, Herts, UK) and transmission electron 114 
microscopy (TEM) (1210 Jeol, Herts, UK) by the method of Lemar, Turner & Lloyd (2002), 115 
except that for TEM, pellets were embedded in Araldite resin, not Spurr.  Electron 116 
micrographs of untreated and treated cells were compared to identify structural changes 117 
such as altered shape, modified surface layers, the presence of electron dense material, 118 
and cellular debris. 119 
 120 
Results.  Inhibition studies:  MIC and MBC were found to be 9.5 and 12 % (w/v) manuka, 121 
which agreed well with previous reports (Cooper & Molan 1999; Cooper Halas & 122 
Molan.2002). The close proximity of these two values indicated a bactericidal mode of 123 
inhibition, which was confirmed by time-kill studies (Fig. 1). The time estimated to achieve a 124 
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3 log reduction was 257 minutes, and a 5 log reduction was be expected to be achieved 125 
within 24 hours.   126 
Structural studies: Cells in both the exponential and stationary phases of growth were used 127 
in electron microscopy experiments, because stationary phase cells are often less 128 
susceptible to antimicrobial agents than exponential cells. However the structural changes 129 
observed in exponential and stationary phase cells were similar and therefore only electron 130 
micrographs of exponential cells are presented here. 131 
Observations with SEM: Compared to the smooth surface layers of untreated cells, honey 132 
treated Ps. aeruginosa cells exhibited marked cell surface changes as furrows and blebs 133 
(Fig 1a). Cell length was shortened and extruded cellular material was present. In untreated 134 
samples 2% cells were found to have cell surface irregularities, whereas 80 and 60 % cells 135 
of exponential and stationary cultures, respectively were irregular (Table 1).  136 
Observations with TEM: Damaged cell surfaces and debris were clearly evident in TEMs of 137 
honey treated P. aeruginosa (Fig. 3d), and cell interiors appeared to be more densely 138 
stained.  139 
Discussion. MICs obtained in this study were similar but not identical to values previously 140 
reported (Cooper, Halas & Molan, 2002; Cooper, Molan & Harding, 2002; Wahdan, 1998; 141 
Willix, Molan & Harfoot, 1992), but this is not unexpected as honey is a natural product and 142 
never consistent in quality. For medicinal purposes it is usually collected from identified hives 143 
and only samples of proven antibacterial potency are utilised (Allen, Molan & Reid, 1991). 144 
MBCs (Table 1), time-kill plots (Fig.1) and the determination of the time of commitment to 145 
death confirmed a bactericidal rather than bacteriostatic mode of inhibition for both bacteria.  146 
Previously published work  shows that S. aureus was more susceptible to manuka honey 147 
than P. aeruginosa, S. aureus at approximately three times MIC values lost viability at a 148 
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slower rate than P. aeruginosa exposed to twice the MIC. These observations suggest that 149 
manuka affects each species differently. 150 
The structural studies conclusively demonstrate that manuka honey elicited distinct 151 
cytological changes P. aeruginosa. The changes to cell surface and shape seen in SEMs of 152 
pseudomonads were extensive. The presence of shortened rods indicated a stress 153 
response (Oliver, 2005).   154 
In TEMs of treated cells, cell debris provided evidence of leakage of cellular material and 155 
lysis of whole cells, and was obvious with Pseudomonas. Honey seems to have a greater 156 
affect on the surface layers of P. aeruginosa than it does for S. aureus.  157 
 158 
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Table 1: Structural changes observed in SEMs of Ps. aeuginosa 199 
 % of exponential phase cells 
with structural changes 
% of stationary phase cells 
with structural changes 
No honey 2 (n=1568) 2 (n=24514) 
Honey 80 (n=1100) 60 (n=283) 
Mann-Whitney test p = 0.02 p = 0001 
 200 
n = number of cells observed  201 
 202 
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Figure 1: time-kill experiments 203 
 204 
Ps. aeruginosa in nutrient broth (), Ps.aeruginosa in nutrient broth containing 20 % (w/v) 205 
M109 Manuka honey (), 206 
 207 
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 210 
Figure 2: The effect of manuka honey on the structure of exponential phase 211 
bacteria as seen by SEM  212 
 213 
a Exponential phase cells of Ps. .aeruginosa incubated with buffer for 8 hours at 37oC 214 
as viewed by SEM at 10,000 magnification 215 
b Exponential phase cells of Ps. aeruginosa incubated with buffer containing 20 % (w/v) 216 
manuka honey for 8 hours at 37oC as viewed by SEM at 10,000 magnification 217 
 218 
 219 
 220 
 221 
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 222 
Figure 3: The effect of manuka honey on the structure of exponential phase 223 
bacteria as seen by TEM 224 
a Exponential phase cells of Ps. aeruginosa incubated with buffer for 8 hours at 37oC as 225 
viewed by TEM at 10,000 magnification 226 
b Exponential phase cells of Ps. aeruginosa incubated with buffer containing 20 %(w/v) 227 
manuka honey for 8 hours at 37oC as viewed by TEM at 10,000 magnification 228 
 229 
 230 
 231 
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